Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial (poster)
Pannus, Pieter ; Depickère, Stéphanie ; Kemlin, Delphine ; Houben, Sarah ; Neven, Christophe Y. ; Hendrickx, Leo ; Michiels, Johan ; Willems, Elisabeth ; De Craeye, Stéphane ; ... show 10 more
Pannus, Pieter
Depickère, Stéphanie
Kemlin, Delphine
Houben, Sarah
Neven, Christophe Y.
Hendrickx, Leo
Michiels, Johan
Willems, Elisabeth
De Craeye, Stéphane
Citations
Altmetric:
Abstract
Description
Date
2022-07-01
Journal Title
Journal ISSN
Volume Title
Publisher
Chapter title
Publication type
Scientific poster, presentation or proceeding
Research Projects
Organizational Units
Journal Issue
Keywords
Citation
Topic(s)
Disease caused by SARS-CoV-2 (COVID-19) #22545#
Immune system #22392#
immunity #22393#
Vaccine-preventable diseases #12989#
Immune system #22392#
immunity #22393#
Vaccine-preventable diseases #12989#
Related project
BelCoVac #1000164#
